Hims Pulls Cheaper Wegovy Pill After Federal Scrutiny
MONDAY, Feb. 9, 2026 — Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws.
The online health company…
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The wellness platform pulled its version of the drug just days after launching it.
Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking ‘hundreds of millions’ in damages
Novo Nordisk on Monday said it is suing telehealth company Hims & Hers for allegedly infringing its patent on the weight loss medication semaglutide — not just for the pill version but also for the injectable …
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent.
Can Ozempic Cure Addiction?
GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.
Hims says it will stop selling GLP-1 pill, after legal pressure from US
The telehealth company Hims & Hers said it will no longer sell a compounded version of Novo Nordisk’s Wegovy pill, just days after announcing the new product.
The move comes after Novo, which launched its …
You’ve reached your weight loss goal on GLP-1 medications. What now?
GLP-1 drugs have ushered in a new era in weight loss.
The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Welcome back to another edition of Endpoints Weekly! It’s Super Bowl weekend with the Patriots and Seahawks fighting for the championship. While our many Boston-area readers are surely excited, most of us here in New …
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs
US calls for DOJ investigation of Hims over GLP-1 drugs
The US government said it will refer telehealth and GLP-1 company Hims & Hers to the Department of Justice for investigation, following the company’s controversial launch of a compounded version of Novo …